<DOC>
	<DOCNO>NCT01732822</DOCNO>
	<brief_summary>The purpose study compare effect ticagrelor clopidogrel patient Peripheral Artery Disease .</brief_summary>
	<brief_title>A Study Comparing Cardiovascular Effects Ticagrelor Clopidogrel Patients With Peripheral Artery Disease</brief_title>
	<detailed_description>A randomized , double-blind , parallel group , multicentre phase IIIb study compare ticagrelor clopidogrel treatment risk cardiovascular death , myocardial infarction ischemic stroke patient establish Peripheral Artery Disease ( EUCLID Examining Use tiCagreLor In paD )</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Male Female patient 50 year old old Symptomatic peripheral artery disease Patients need dual antiplatlet drug treatment start study Planned revascularisation amputation Patients know bleed disorder Patients history intracranial bleed Patients consider risk bradycardic event unless already treat permanent pacemaker</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Peripheral artery disease Atherothrombotic event Atherosclerosis</keyword>
</DOC>